Bortezomib-based Optimized therapy Aiming Disease control in Japan.
Phase of Trial: Phase III
Latest Information Update: 16 May 2016
At a glance
- Drugs Bortezomib (Primary) ; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Adverse reactions
- Acronyms BROAD-J
- 27 Apr 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 21 Feb 2012 New trial record